Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63(1):11–30
Article
Google Scholar
Walentowicz-Sadlecka M, Malkowski B, Walentowicz P, Sadlecki P, Marszalek A, Pietrzak T, Grabiec M (2014) The preoperative maximum standardized uptake value measured by 18F-FDG PET/CT as an independent prognostic factor of overall survival in endometrial cancer patients. Biomed Res Int 2014:234813
Article
Google Scholar
Bi FF, Li D, Yang Q (2013) Hypomethylation of ETS transcription factor binding sites and upregulation of PARP1 expression in endometrial cancer. BioMed Res Int 2013:946268
PubMed
PubMed Central
Google Scholar
Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I (2005) Endometrial cancer. Lancet 366(9484):491–505
Article
Google Scholar
Bakkum-Gamez JN, Gonzalez-Bosquet J, Laack NN, Mariani A, Dowdy SC (2008) Current issues in the management of endometrial cancer. Mayo Clin Proc 83:97–112
Article
Google Scholar
Kikuchi A, Yanase T, Sasagawa M, Honma S (2017) The role of para-aortic lymphadenectomy in stage IIIC endometrial cancer: a single-institute study. J Obstet Gynaecol 37(4):510–513
Article
Google Scholar
Todo Y, Takeshita S, Okamoto K, Yamashiro K, Kato H (2017) Implications of para-aortic lymph node metastasis in patients with endometrial cancer without pelvic lymph node metastasis. J Gynecol Oncol 28(5):e59
Article
Google Scholar
Atri M, Zhang Z, Dehdashti F, Lee SI, Marques H, Ali S, Koh WJ, Mannel RS, DiSilvestro P, King SA, Pearl M, Zhou X, Plante M, Moxley KM, Gold M (2017) Utility of PET/CT to evaluate retroperitoneal lymph node metastasis in high-risk endometrial cancer: results of ACRIN 6671/GOG 0233 trial. Radiology 283(2):450–459
Article
Google Scholar
Lee HJ, Lee JJ, Park JY, Kim JH, Kim YM, Kim YT, Nam JH (2017) Prognostic value of metabolic parameters determined by preoperative 18F-FDG PET/CT in patients with uterine carcinosarcoma. J Gynecol Oncol 28(4):e43
Article
Google Scholar
Lindqvist E, Wedin M, Fredrikson M, Kjølhede P (2017) Lymphedema after treatment for endometrial cancer—a review of prevalence and risk factors. Eur J Obstet Gynecol Reprod Biol 211:112–121
Article
Google Scholar
Pulman KJ, Dason ES, Philp L, Bernardini MQ, Ferguson SE, Laframboise S, Atenafu EG, May T (2017) Comparison of three surgical approaches for staging lymphadenectomy in high-risk endometrial cancer. Int J Gynaecol Obstet 136(3):315–319
Article
Google Scholar
Bae HS, Lim MC, Lee JS, Lee Y, Nam BH, Seo SS, Kang S, Chung SH, Kim JY, Park SY (2016) Postoperative lower extremity edema in patients with primary endometrial cancer. Ann Surg Oncol 23(1):186–195
Article
Google Scholar
Mariani A, Webb MJ, Keeney GL, Haddock MG, Calori G, Podratz KC (2000) Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol 182(6):1506–1519
Article
CAS
Google Scholar
Tsujikawa T, Yoshida Y, Kudo T, Kiyono Y, Kurokawa T, Kobayashi M, Tsuchida T, Fujibayashi Y, Kotsuji F, Okazawa H (2009) Functional images reflect aggressiveness of endometrial carcinoma: estrogen receptor expression combined with 18F-FDG PET. J Nucl Med 50(10):1598–1604
Article
CAS
Google Scholar
Chung HH, Nam BH, Kim JW, Kang KW, Park NH, Song YS, Chung JK, Kang SB (2010) Preoperative [18F]FDG PET/CT maximum standardized uptake value predicts recurrence of uterine cervical cancer. Eur J Nucl Med Mol Imaging 37:1467–1473
Article
Google Scholar
Ghooshkhanei H, Treglia G, Sabouri G, Davoodi R, Sadeghi R (2014) Risk stratification and prognosis determination using 18F-FDG PET imaging in endometrial cancer patients: a systematic review and meta-analysis. Gynecol Oncol 132(3):669–676
Article
Google Scholar
Lee HJ, Ahn BC, Hong CM, Song BI, Kim HW, Kang S, Jeong SY, Lee SW, Lee J (2011) Preoperative risk stratification using (18)F-FDG PET/CT in women with endometrial cancer. Nuklearmedizin 50(5):204–213
Article
CAS
Google Scholar
Husby JA, Reitan BC, Biermann M, Trovik J, Bjørge L, Magnussen IJ, Salvesen ØO, Salvesen HB, Haldorsen IS (2015) Metabolic tumor volume on 18F-FDG PET/CT improves preoperative identification of high-risk endometrial carcinoma patients. J Nucl Med 56(8):1191–1198
Article
CAS
Google Scholar
Pak K, Cheon GJ, Nam HY, Kim SJ, Kang KW, Chung JK, Kim EE, Lee DS (2014) Prognostic value of metabolic tumor volume and total lesion glycolysis in head and neck cancer: a systematic review and metaanalysis. J Nucl Med 55(6):884–890
Article
CAS
Google Scholar
Colombo N, Creutzberg C, Amant F, Bosse T, González-Martín A, Ledermann J, Marth C, Nout R, Querleu D, Mirza MR, Sessa C, ESMO-ESGO-ESTRO Endometrial Consensus Conference Working Group (2016) ESMO-ESGO-ESTRO Consensus Conference on endometrial cancer. Ann Oncol 27:16–41
Article
CAS
Google Scholar
Bristow RE, Zahurak ML, Alexander CJ, Zellars RC, Montz FJ (2003) FIGO stage IIIC endometrial carcinoma: resection of macroscopic nodal disease and other determinants of survival. Int J Gynecol Cancer 13(5):664–672
Article
CAS
Google Scholar
Winer I, Ahmed QF, Mert I, Bandyopadhyay S, Cote M, Munkarah AR, Hussein Y, Al-Wahab Z, Elshaikh MA, Alosh B, Schultz DS, Mahdi H, Nucci MR, Van de Vijver KK, Morris RT, Oliva E, Ali-Fehmi R (2015) Significance of lymphovascular space invasion in uterine serous carcinoma: what matters more; extent or presence? Int J Gynecol Pathol 34(1):47–56
Article
CAS
Google Scholar
Gee MS, Atri M, Bandos AI, Mannel RS, Gold MA, Lee SI (2018) Identification of distant metastatic disease in uterine cervical and endometrial cancers with FDG PET/CT: analysis from the ACRIN 6671/GOG 0233 multicenter trial. Radiology 287(1):176–184
Article
Google Scholar
Concin N, Matias-Guiu X, Vergote I, Cibula D, Mirza MR, Marnitz S, Ledermann J, Bosse T, Chargari C, Fagotti A, Fotopoulou C, Gonzalez Martin A, Lax S, Lorusso D, Marth C, Morice P, Nout RA, O’Donnell D, Querleu D, Raspollini MR, Sehouli J, Sturdza A, Taylor A, Westermann A, Wimberger P, Colombo N, Planchamp F, Creutzberg CL (2021) ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. Int J Gynecol Cancer 31(1):12–39
Article
Google Scholar
Shen G, Zhou H, Jia Z, Deng H (2015) Diagnostic performance of diffusion-weighted MRI for detection of pelvic metastatic lymph nodes in patients with cervical cancer: a systematic review and meta-analysis. Br J Radiol 88(1052):20150063
Article
Google Scholar
Antonsen SL, Jensen LN, Loft A, Berthelsen AK, Costa J, Tabor A, Qvist I, Hansen MR, Fisker R, Andersen ES, Sperling L, Nielsen AL, Asmussen J, Høgdall E, Fagö-Olsen CL, Christensen IJ, Nedergaard L, Jochumsen K, Høgdall C (2013) MRI, PET/CT and ultrasound in the preoperative staging of endometrial cancer—a multicenter prospective comparative study. Gynecol Oncol 128(2):300–308
Article
CAS
Google Scholar
Kim HJ, Cho A, Yun M, Kim YT, Kang WJ (2016) Comparison of FDG PET/CT and MRI in lymph node staging of endometrial cancer. Ann Nucl Med 30(2):104–113
Article
Google Scholar
Fasmer KE, Gulati A, Dybvik JA, Ytre-Hauge S, Salvesen Ø, Trovik J, Krakstad C, Haldorsen IS (2020) Preoperative 18F-FDG PET/CT tumor markers outperform MRI-based markers for the prediction of lymph node metastases in primary endometrial cancer. Eur Radiol 30(5):2443–2453
Article
Google Scholar
Wang T, Sun H, Guo Y, Zou L (2019) 18F-FDG PET/CT quantitative parameters and texture analysis effectively differentiate endometrial precancerous lesion and early-stage carcinoma. Mol Imaging 18:1536012119856965
Article
Google Scholar
Trousil S, Lee P, Pinato DJ, Ellis JK, Dina R, Aboagye EO, Keun HC, Sharma R (2014) Alterations of choline phospholipid metabolism in endometrial cancer are caused by choline kinase alpha overexpression and a hyperactivated deacylation pathway. Cancer Res 74(23):6867–6877
Article
CAS
Google Scholar
Rockall AG, Barwick TD, Wilson W, Singh N, Bharwani N, Sohaib A, Nobbenhuis M, Warbey V, Miquel M, Koh DM, De Paepe KN, Martin-Hirsch P, Ghaem-Maghami S, Fotopoulou C, Stringfellow H, Sundar S, Manchanda R, Sahdev A, Hackshaw A, Cook GJ, MAPPING Study Group (2021) Diagnostic accuracy of FEC-PET/CT, FDG-PET/CT, and diffusion-weighted MRI in detection of nodal metastases in surgically treated endometrial and cervical carcinoma. Clin Cancer Res 27(23):6457–6466
Article
CAS
Google Scholar
FESPET Study: Female EStrogen recePtor in Endometrial Cancer Treatment (FESPET). https://clinicaltrials.gov/ct2/show/NCT03489473.
Chang MC, Chen JH, Liang JA, Yang KT, Cheng KY, Kao CH (2012) 18F-FDG PET or PET/CT for detection of metastatic lymph nodes in patients with endometrial cancer: a systematic review and meta-analysis. Eur J Radiol 81(11):3511–3517
Article
Google Scholar
Bollineni VR, Ytre-Hauge S, Bollineni-Balabay O, Salvesen HB, Haldorsen IS (2016) High diagnostic value of 18F-FDG PET/CT in endometrial cancer: systematic review and meta-analysis of the literature. J Nucl Med 57(6):879–885
Article
CAS
Google Scholar
Kitajima K, Suenaga Y, Ueno Y, Kanda T, Maeda T, Takahashi S, Ebina Y, Miyahara Y, Yamada H, Sugimura K (2013) Value of fusion of PET and MRI for staging of endometrial cancer: comparison with 18F-FDG contrast-enhanced PET/CT and dynamic contrast-enhanced pelvic MRI. Eur J Radiol 82(10):1672–1676
Article
Google Scholar
Bian LH, Wang M, Gong J, Liu HH, Wang N, Wen N, Fan WS, Xu BX, Wang MY, Ye MX, Meng YG (2019) Comparison of integrated PET/MRI with PET/CT in evaluation of endometrial cancer: a retrospective analysis of 81 cases. PeerJ 7:e7081
Article
Google Scholar
Ayhan A, Tuncer R, Tuncer ZS, Yüce K, Küçükali T (1994) Correlation between clinical and histopathologic risk factors and lymph node metastases in early endometrial cancer (a multivariate analysis of 183 cases). Int J Gynecol Cancer 4(5):306–309
Article
Google Scholar